Lyfegen HealthTech AG
↗Basel, Switzerland
Lyfegen is a Swiss-based health technology company that provides a SaaS-based rebate management and drug pricing platform. The company acts as a neutral third party, helping healthcare payers, governments, and pharmaceutical companies manage complex drug pricing agreements, automate rebate execution, and simulate financial impacts to improve patient access to innovative therapies.
Founded in 2018, the company has developed a patent-protected platform that digitalizes value-based healthcare contracting. Lyfegen's solutions are designed to reduce administrative burdens, increase transparency in pricing negotiations, and ensure that high-cost therapies are more affordable and accessible within healthcare systems globally.
CLASSIFICATION
Company Type:Digital Health
Therapeutic Areas:-
Industry:Digital Health
Sub-Industry:HealthTech / SaaS / Drug Pricing & Rebate Management
SIZE & FINANCIALS
Employees:1-50
Founded:2018
Ownership:private
Status:operating
FUNDING
Stage:Series A
Total Raised:$17.1M
Investors:TX Ventures, aMoon Fund, SwissHealth Ventures, APEX Ventures, MassChallenge
0
CORPORATE STRUCTURE
Key Partnerships:Johnson & Johnson (Value-based healthcare strategy implementation), EVERSANA (AI-driven drug pricing and access insights), EGK-Gesundheitskasse (Drug pricing cooperation)
COMPETITION
Position:Emerging
Competitors:MMIT Network, Epocrates, Yuimedi
LEADERSHIP
Key Executives:
Girisha Fernando - CEO & Co-Founder
Michel Mohler - CFO & Co-Founder
Nico Mros - Co-Founder
Scientific Founders:Girisha Fernando, Michel Mohler, Nico Mros
LINKS
⚠
Is this information incorrect? This profile was AI-generated from publicly available sources and may contain errors. If you are a representative of Lyfegen HealthTech AG and believe any information on this page is inaccurate, we will promptly correct or remove it.REPORT AN ERROR
Disclaimer: IntuitionLabs.ai is not affiliated with, endorsed by, or associated with Lyfegen HealthTech AG. The information on this page was compiled using AI from publicly available sources and may be incomplete, outdated, or contain errors. We are committed to correcting inaccuracies promptly upon notice. For official information, please visit the company's website directly.